Balqees M Al Rafayah: What is Hemophilia?
Balqees M Al Rafayah, Lab supervisor at Mutah University, shared on LinkedIn:
”What is hemophilia?
• A hereditary bleeding disorder in which the blood does not clot properly due to a deficiency of one of the clotting factors.
• It is inherited either as a sex-linked (X-linked) recessive trait — more common in males while females are carriers — or as an autosomal recessive disorder in the case of Hemophilia C.
– How many types of hemophilia are there and what are they?
There are three main types of hemophilia: Hemophilia A, Hemophilia B, and Hemophilia C.
Each type is caused by a deficiency in a specific clotting factor.
Hemophilia A:
• Also known as classical hemophilia.
• It is the most common hereditary clotting factor deficiency.
• Caused by an X-linked recessive mutation.
• Results from a deficiency in clotting factor VIII.
• Symptoms may include:
– Joint and soft tissue bleeding
– Spontaneous hematuria
– Excessive bruising
Hemophilia B:
• Also known as Christmas disease.
• Caused by an X-linked recessive mutation.
• Results from a deficiency in clotting factor IX.
• Symptoms are similar to Hemophilia A:
– Joint and soft tissue bleeding
– Spontaneous hematuria
– Excessive bruising
Hemophilia C:
• A rare form of hemophilia.
• Inherited as an autosomal recessive disorder.
• Caused by a deficiency in clotting factor XI.
• Usually results in milder symptoms, such as:
– Nosebleeds
– Easy bruising”

Stay updated with Hemostasis Today.
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon